Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS

NCT03567577 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

ARDS

Interventions

DRUG: Solnatide 25 mg powder for reconstitution for solution for inhalation
DRUG: 0.9% Saline Solution

Sponsor

Apeptico Forschung und Entwicklung GmbH